Test Your ASN Knowledge!
The ASN 2022 PhysQuiz was created by the editorial staff at Physician’s...
Read MoreDec 16, 2022
The ASN 2022 PhysQuiz was created by the editorial staff at Physician’s...
Read MoreDec 6, 2022
Early findings from the PROTECT trial,1 presented at the 2022 American Society of Nephrology’s...
Read MoreNov 21, 2022
Results from the MIRROR RCT trial, presented at the 2022 American Society of Nephrology’s Kidney...
Read MoreNov 14, 2022
Compared with their White counterparts, gout is more prevalent in Black adults, according to the...
Read MoreNov 14, 2022
Compared with patients with gout who did not experience a cardiovascular (CV) event, those who did...
Read MoreOct 28, 2022
Thursday: 08:00 AM EDT – 09:30 AM EDT SPECIAL SESSIONS Joint ASN-National Academy of Medicine Opening Plenary: ASN President’s Address, Expert Panel “Preventing the Next Pandemic” 10:00 AM EDT –...
Read MoreOct 28, 2022
In support of improving patient care, the American Society of Nephrology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and...
Read MoreOct 28, 2022
Are you unable to make it to ASN 2022 but still want access to all the latest research? Don’t worry because ASN has you covered. Fortunately, ASN provides downloadable journals for all their recent conferences. To find all...
Read MoreOct 28, 2022
Patients (pts) who received methotrexate (MTX) in combination with placebo [PBO] co-therapy to...
Read MoreOct 27, 2022
For the treatment of gout in chronic kidney disease CKD patients, there needs to be more...
Read MoreOct 26, 2022
Gout, chronic kidney disease, type 2 diabetes, and cardiovascular disease are all linked to...
Read MoreOct 26, 2022
Pegloticase’s effectiveness is dramatically enhanced when immunomodulator co-therapy is used...
Read More